SAB BIOTHERAPEUTICS, INC. Cash Equivalents, at Carrying Value
SAB BIOTHERAPEUTICS, INC. (SABS) had Cash Equivalents, at Carrying Value of $0 as of 2021-09-30, per its 10-Q filed 2021-11-22.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2021-11-22
- 2021-09-30: Cash Equivalents, at Carrying Value $0.00.
- 2021-06-30: Cash Equivalents, at Carrying Value $0.00.
- 2020-12-31: Cash Equivalents, at Carrying Value $0.00.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2021-09-30 | $0.00 10-Q · filed 2021-11-22 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-09 |
| 2020-12-31 | $0.00 10-Q · filed 2021-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |